she stated. Distributing the new equipment is expected to strengthen the network of services for examining and detecting TB pathogens through genetic testing of samples. There will now be a total of ...
Tuberculosis (TB) remains a significant global health challenge, being one of the leading causes of death from infectious diseases. The causative agent, ...
BioVersys plans a Q1 2025 IPO on the SIX Swiss Exchange to raise 80 million francs for Phase III trials of BV100 targeting CRAB and Phase II development of alpibectir for TB meningitis. The company ...
Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...
Understanding bacterial growth mechanisms can potentially help uncover novel drug targets that are crucial for maintaining cellular viability, particularly for bacterial pathogens. In this important ...